Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
allergan
ascension ventures
cancer
codiak biosciences
cormorant asset management
crispr
cutaneous t-cell lymphoma
cynthia collins
digital health
drugs
editas medicine
exosome
fda
gene editing
inova strategic investments
investing
jazz pharmaceuticals
katrine bosley
leber congenital amaurosis
longwood fund
medical device
national top stories
new york blog main
osf ventures
perceptive advisors
remendium labs
renovia
sarepta therapeutics
software
startups
western technology investment
women's health
What
clinical
3
×
million
3
×
aiming
allergan
based
begin
biosciences
bio’s
blessing
bosley
brings
bubbles
cells
ceo
check
class
closed
codiak
company
crispr
cusp
depart
digital
editas
editing
exosome
exosomes
experimental
financing
formed
fund
gene
humans
incontinence
ipo
katrine
medicine
medicines
new
partner
Language
unset
Current search:
boston
×
million
×
clinical
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
